Niagen Bioscience, Inc. (NAGE) insider trading.
In Q3 2026, insiders at Niagen Bioscience, Inc. reported 3 non-derivative transactions on 3 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.
- Transactions
- 3
- Purchases (P)
- 0
- Sales (S)
- 0
- Net shares, P minus S
- 0
- Insiders
- 3
- Last filed
- 2026-07-08
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Fried Robert N | Director, Officer · Chief Executive Officer | 1 | 0 | 0 |
| Pamir Ozan | Officer · Chief Financial Officer | 1 | 0 | 0 |
| Lopez Carlos Luis | Officer · SVP, General Counsel | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-06-30 | Fried Robert N | A (A) | 1,106 | $2.71 | 1,060,087 | Form 4 |
| 2026-06-30 | Pamir Ozan | A (A) | 4,255 | $2.71 | 11,627 | Form 4 |
| 2026-06-30 | Lopez Carlos Luis | A (A) | 2,314 | $2.71 | 4,565 | Form 4 |
Transaction codes in this quarter
Get NAGE insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1386570&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · NAGE company page · Niagen Bioscience, Inc. on SEC.gov
Questions
Are insiders buying or selling Niagen Bioscience, Inc. (NAGE)?
In Q3 2026, insiders at Niagen Bioscience, Inc. reported 3 non-derivative transactions on 3 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Niagen Bioscience, Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/nage.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.